MWN109 injection safety study in healthy volunteers
Part of Hormones & metabolism clinical trials.
This trial tests an investigational injection called MWN109 to see if it is safe and how the body processes it. It is for healthy adults only, and the results will help decide if the drug should be tested in people with medical conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 50 years old.
- Your body mass index (BMI) must be between 19 and 40 for one part of the study, or between 27 and 45 for another part.
- Your weight must have stayed steady (within 5%) for the past 3 months.
- You must be willing to use birth control and not donate sperm or eggs during the study and for 4 months after.
- You must be generally healthy with no major medical conditions like heart disease, diabetes, or stomach problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage (Phase 1) safety test of a new investigational drug called BW-20805-2-1001 in people without serious health conditions. Researchers want to understand how the drug is tolerated and processed by the body when given as an injection.
This trial tests a new injection called SYH2092 in healthy adults, not for treating a disease. Participation helps researchers understand how the drug works in the body and if it is safe. If you qualify, you may be compensated for your time.
This study tests a new injected medicine to see if it is safe and how it works in people who are overweight or obese, as well as in healthy volunteers. It may help with weight loss, but it is an early-phase trial to check safety first.
This study tests an investigational injection called MWN109 to see if it helps people with overweight or obesity lose weight. It may offer a new treatment option for those who haven't been able to manage their weight with lifestyle changes alone.
This trial tests a new tablet called MWN109 in healthy adults to see how safe it is and how the body handles it. It has two parts: one for people with a wide range of body weights, and another specifically for people with higher body weight. The results will help guide future studies.
This study tests a new experimental injection in healthy volunteers to see if it's safe and how well the body absorbs it. Researchers will compare it with other similar treatments to understand how it works.
Hear when a new Overweight or Obese trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.